Relapsed and primary refractory Diffuse Large Cell Lymphoma (DLCL) salvaged with Involved Field Radiotherapy (IFRT) & High Dose Chemotherapy (HDCT) followed by Autologous Stem Cell Transplantation (ASCT)

被引：0
|
作者：
Hoppe, B. S. [1 ]
Moskowitz, C. H. [1 ]
Moskowitz, C. S. [1 ]
Filippa, D. A. [1 ]
Kewalramani, T. [1 ]
Yahalom, J. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 69卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2007.07.1778
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S537 / S537
页数：1
相关论文
共 50 条
  • [1] Intensified chemotherapy followed by myeloablative therapy and autologous stem cell transplantation (ASCT) as first line therapy in high risk diffuse large cell lymphoma (DLCL).
    Vitolo, U
    Cortellazzo, S
    Liberati, AM
    Freilone, R
    Falda, M
    Bertini, M
    Botto, B
    Cinieri, S
    Locatelli, F
    Marmont, F
    Pizzuti, M
    Rossi, A
    Viero, P
    Grignani, F
    Barbui, T
    Resegotti, L
    BLOOD, 1995, 86 (10) : 1819 - 1819
  • [2] High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
    Aoki, T.
    Shimada, K.
    Suzuki, R.
    Izutsu, K.
    Tomita, A.
    Maeda, Y.
    Takizawa, J.
    Mitani, K.
    Igarashi, T.
    Sakai, K.
    Miyazaki, K.
    Mihara, K.
    Ohmachi, K.
    Nakamura, N.
    Takasaki, H.
    Kiyoi, H.
    Nakamura, S.
    Kinoshita, T.
    Ogura, M.
    BLOOD CANCER JOURNAL, 2015, 5 : e372 - e372
  • [3] High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
    T Aoki
    K Shimada
    R Suzuki
    K Izutsu
    A Tomita
    Y Maeda
    J Takizawa
    K Mitani
    T Igarashi
    K Sakai
    K Miyazaki
    K Mihara
    K Ohmachi
    N Nakamura
    H Takasaki
    H Kiyoi
    S Nakamura
    T Kinoshita
    M Ogura
    Blood Cancer Journal, 2015, 5 : e372 - e372
  • [4] High dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) in Primary Breast Lymphoma (PBL).
    Negret, LM
    Gentile, TC
    Lemke, SM
    BLOOD, 2000, 96 (11) : 373B - 373B
  • [5] High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma
    Rancea, Michaela
    Monsef, Ina
    von Tresckow, Bastian
    Engert, Andreas
    Skoetz, Nicole
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (06):
  • [6] High dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma.
    Holland, D. W.
    Engelhardt, B. G.
    Goodman, S. A.
    Greer, J. P.
    Morgan, D. S.
    Schuening, F. G.
    Wolff, S.
    Bitting, R.
    Sulur, P.
    Stein, R. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 434S - 434S
  • [7] Autologous stem cell transplantation (ASCT) for relapsed/refractory follicular large cell lymphoma (FLCL).
    Mollee, P
    Song, K
    Keating, A
    Tsang, R
    Crump, M
    BLOOD, 2002, 100 (11) : 183A - 183A
  • [8] High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma
    Alkhaldi, Hanan
    Reinhardt, Alec
    Barnett, Melissa
    Kundu, Suprateek
    Hosing, Chitra
    Ramdial, Jeremy
    Saini, Neeraj
    Srour, Samer
    Alousi, Amin
    Kebriaei, Partow
    Popat, Uday
    Qazilbash, Muzaffar
    Champlin, Richard
    Shpall, Elizabeth J.
    Gulbis, Allison
    Shigle, Terri Lynn
    Dabaja, Bouthaina
    Pinnix, Chelsea
    Ahmed, Sairah
    Steiner, Raphael
    Andersson, Borje S.
    Nieto, Yago
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (11): : 690 - 694
  • [9] Outcomes of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Followed by High-Dose Chemotherapy and Autologous Stem Cell Transplantation (HDCT/ASCT) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    Abdallah, Al-Ola
    Mohyuddin, Ghulam Rehman
    Mahmoudjafari, Zahra
    Shebli, Atrash
    Kawsar, Hameem
    Sigle, Monia
    Shune, Leyla
    McGuirk, Joseph
    Ganguly, Siddhartha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S303 - S303
  • [10] Outcomes of daratumumab, pomalidomide, and dexamethasone (DPd) followed by high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) in patients with relapsed/refractory myeloma RRMM.
    Abdallah, Al-Ola A.
    Dias, Ajoy
    Kawsar, Hameem, I
    Mohyuddin, Ghulam Rehman
    Sigle, Monia
    Mahmoudjafari, Zahra
    Shune, Leyla Osman
    McGuirk, Joseph
    Ganguly, Siddhartha
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345